Related Experiment Videos
Screening for mitochondrial DNA (mtDNA) point mutations using nonradioactive single strand conformation polymorphism
M Jaksch1, K D Gerbitz, C Kilger
1Institute of Clinical Chemistry, München, Germany.
Clinical Biochemistry
|October 1, 1995
Summary
Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) effectively screens for mitochondrial DNA point mutations, including those causing Leber's hereditary optic neuropathy (LHON) and MELAS. This method offers high sensitivity for detecting known and novel mutations.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Mitochondrial cytopathies, including Leber's hereditary optic neuropathy (LHON), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), and myoclonus epilepsy with red ragged fibers (MERRF), are linked to specific mitochondrial DNA (mtDNA) point mutations.
- The increasing discovery of novel mutations and the dispersed nature of known mutations across the mitochondrial genome make comprehensive screening via sequencing laborious and time-consuming.
Purpose of the Study:
- To evaluate the utility of polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) as a rapid and efficient screening tool for human mitochondrial point mutations.
- To assess the sensitivity and applicability of the optimized PCR-SSCP method for detecting known and potentially novel mtDNA mutations.
Main Methods:
- Optimization of PCR-SSCP using pUC18 clones with defined sequence differences and length variations in the mitochondrial control region.
- Application of the optimized PCR-SSCP to large patient cohorts with confirmed mtDNA point mutations and healthy controls.
- Comparison of PCR-SSCP results with direct sequencing to determine sensitivity.
Main Results:
- The PCR-SSCP method successfully detected common LHON-associated mutations (nps 11778, 14484, 4216) and the MELAS-associated heteroplasmic mutation (np 3243).
- Several novel polymorphisms and point mutations within the mitochondrial genome were identified.
- The optimized PCR-SSCP achieved a high sensitivity of 93% for clones and 98% for disease controls when validated against direct sequencing.
Conclusions:
- The PCR-SSCP technique, particularly when combined with a non-radioactive silver staining method, is a suitable approach for detecting human mitochondrial point mutations.
- This PCR-SSCP method serves as a valuable screening tool for identifying both known and novel mtDNA mutations, facilitating faster diagnosis and research in mitochondrial diseases.